Semaglutide generally doesnt require dose changes regardless of kidney function
Clinical trial dosing protocol Phase 2 and Phase 3 trials used a titration approach, starting at lower doses and increasing gradually to minimize gastrointestinal side effects
Administered as a once-weekly subcutaneous injection , Ozempic has demonstrated effectiveness in improving glycaemic control in type 2 diabetes
Je gebruikt het product niet voor diagnostische of therapeutische toepassingen, en absoluut niet voor menselijke of dierlijke consumptie
Microdosing GLP-1s: A Doctors Guide to Gentle, Effective Metabolic Reset GLP-1 medicationslike semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound)have changed the way we treat metabolic disorders, insulin resistance, PCOS, and even support hormonal balance through perimenopause and beyond
However, mild side effects such as digestive upset, nausea, and occasional skin reactions may occur, especially when beginning supplementation